Quantcast

WEST VIRGINIA RECORD

Saturday, November 2, 2024

Mylan N.v

Recent News About Mylan N.v View More

  • Racketeering class action suit filed against Mylan for EpiPen prices

    By Kyla Asbury |
    CHARLESTON – A class action lawsuit has been filed against Mylan alleging the company violated consumer protection laws and the Racketeer Influenced and Corrupt Organization Act by upping the price of the epinephrine auto-injector.

  • German drug maker files patent lawsuit against Mylan

    By Jessica Karmasek |
    WHEELING – A German pharmaceutical company has filed a patent infringement lawsuit against Morgantown-based Mylan Pharmaceuticals. Plaintiff Boehringer Ingelheim Pharmaceuticals Inc. contends that defendant Mylan submitted Abbreviated New Drug Applications, or ANDAs, to the Food and Drug Administration seeking the approval to make and sell generic versions of Boehringer’s Tradjenta and Jentadueto tablets. An ANDA is an application for a U.S.